JF DRAF PHARMACEUTICALS CORP.

JF Draf Pharmaceuticals Corp. is an established pharmaceutical company engaged in marketing and distribution of quality ethical pharmaceutical products. The company is registered with the Securities and Exchange Commissions (SEC) and has its Licensed to Operate (LTO) from Food and Drugs Administration (FDA) as importer and marketer/distributor. JF Draf's main objective is to make available highly effective and quality medicines more affordable for patients who need them. The company is continuously negotiating exclusive marketing and distribution rights for various medicines and compounds with reputable pharmaceutical companies worldwide. So far, JF Draf has concluded and signed agreements with companies in Greece, Cyprus, Taiwan, India and China for their Central Nervous System (CNS) products and Antibiotics. JF Draf had their successful company launch on July 17, 2003.